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Abstract
Background: Patients with mild cognitive impairment (MCI) experience alterations of functional parameters, such
as an impaired balance or gait. The current systematic review set out to investigate whether functional objective
performance may predict a future risk of MCI; to compare functional objective parameters in patients with MCI and
a control group; and to assess changes in these parameters after different physical activity interventions.
Methods: Electronic databases, including PubMed, AMED, CINAHL, EMBASE, PEDro and Web of Science as well as grey
literature databases, were searched from inception to February 2020. Cohort studies and Randomized Controlled Trials
(RCTs) were included. The risk of bias of the included studies was assessed independently by reviewers using quality
assessment checklists. The level of evidence per outcome was assessed using the GRADE criteria.
Results: Seventeen studies met inclusion criteria including patients with MCI. Results from RCTs suggested that gait
speed, gait variability and balance may be improved by different physical activity interventions. Cohort studies showed
that slower gait speed, above all, under Dual Task (DT) conditions, was the main impaired parameter in patients with
MCI in comparison with a Control Gorup. Furthermore, cohort studies suggested that gait variability could predict an
incident MCI. Although most of included cohort studies reported low risk of bias, RCTs showed an unclear risk of bias.
Conclusions: Studies suggest that gait variability may predict an incident MCI. Moreover, different gait parameters,
above all under DT conditions, could be impaired in patients with MCI. These parameters could be improved by some
physical activity interventions. Although cohort studies reported low risk of bias, RCTs showed an unclear risk of bias
and GRADE criteria showed a low level of evidence per outcome, so further studies are required to refute our findings.
Prospero: CRD42019119180.
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Background
The global life expectancy is increasing in the last years.
Consequently, morbidity, chronic individual diseases and
the number of people affected by dementia are also in-
creasing [1–5]. Thus, while dementias affected around
46.8 million people worldwide in 2016 [5], it is expected
that in 2050 there will be 115–135 million people suffer-
ing from dementia [6, 7]. There is an increase in the
interest of mild cognitive impairment (MCI), defined as
a clinical stage accounting for cognitive impairment that
often precedes dementia [5, 8–17], and whose preva-
lence in adults of ≥65 years old is 10–20%, increasing
this prevalence with age [5, 8].
Accepted diagnosis criteria of MCI reported that patients
with MCI were characterized by an objective impairment of
cognition that is often not severe enough to interfere with
activities of daily living (ADL), instrumental activities of
daily living (IADL) or in social or occupational functioning
[5, 8, 10–14, 17–21]. In the same way, Petersen [11] deter-
mined that patients with MCI presented very mild degrees
of functional impairment that is difficult to distinguish from
the functional problems of cognitively healthy individuals
of the same age. However, patients with MCI may have
problems in functional tasks [5] and it has been reported
that these patients present the alteration of functional pa-
rameters, such as mobility, muscle strength, balance, gait
dysfunction, or increased risk of falls [8, 22–26]. Slower gait
speed has also been suggested as the mainly altered param-
eter in older populations [23–25, 27–32] which may be a
marker for the preclinical stages of dementia [23, 30–33].
Thus, Doi et al. [34], Eggermont et al. [35] and Deshpande
et al. [36] reported that slower gait speed could be indica-
tive of MCI. Veronese et al. [30] showed an association be-
tween decreased gait speed and low performance in the
Short Physical Performance Battery (SPPB) and cognitive
decline. Other functional tests, such as Timed Up Go
(TUG), Hand Grip Strength Test (HGST), Sit to Stand Test
(STS), or Walking Speed Test (WST), have also been used
to demonstrate the association between the performance
on functional tests and MCI [22, 30, 37, 38].
However, Mirelman et al. [39] reported that patients
with MCI could have functional alterations only identifi-
able through a kinematic analysis conducted in their
case with an inertial sensor. In this way, Bahureksa et al.
[40] revealed that kinematic gait parameters such as vel-
ocity, stride length, and stride time best discriminated
patients with MCI from cognitively healthy individuals
under single task (ST) conditions and, above all, under
dual task (DT) conditions. Balance parameters such as
anterior-posterior and medio-lateral sway position also
were identified as significant discriminators [40]. Kine-
matic measurements are frequently used by physicians
and researchers to quantify normal and pathological
movements and could allow to identify altered objective
functional parameters in patients with MCI [41]. The
identification of changes in functional objective parameters
could be relevant for targeting specific interventions aiming
to prevent further functional decline or to improve the func-
tionality of patients with MCI. Currently, no drug has been
shown to be effective for MCI [8, 17, 18, 42]. However, it has
been reported that the combination of aerobic exercise, bal-
ance training, cognitive training, the Mediterranean diet and
social commitment could reduce the risk of further cognitive
impaiment and may improve cognition, mobility, balance
and quality of life in patients with MCI [8, 17, 18, 43, 44].
Considering this, the main objectives of this systematic re-
view were (1) to examine if functional kinematic parameters
may predict a future risk of MCI; (2) to compare these func-
tional objective parameters in patients with MCI and a con-
trol group; (3) to assess longitudinal changes in these
parameters after different physical activity interventions. The
secondary objectives were (1) to assess the risk of bias of the
included studies using The Newcastle-Ottawa Quality As-
sessment Scale (NOS) and The Cochrane Collaboration’s
tool; (2) to assess the level of evidence per outcome using
the Grading of Recommendations Assessment, Development
and Evaluation (GRADE).
Methods
This systematic review was carried out in accordance
with the Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) statement [45]. The
PRISMA checklist for this trial is available in supple-
mentary appendix A. The systematic review protocol
was registered at the International Prospective Register
of Systematic Reviews (PROSPERO: CRD42019119180).
Data sources and search strategy
A systematic search was performed by two independent
reviewers (IJ-FA and A-CV) from inception to February
2020 using optimised search strategies in the following
electronic databases: PubMed, AMED, CINAHL,
EMBASE, PEDro, Web of Science. A sensitive search
strategy using relevant search terms that were developed
from Medical Subject Headings (MeSH), and keywords
from other similar studies were used: ‘mild cognitive
impaiment’ (MeSH Terms), ‘kinetics’ (MeSH Terms),
‘acceleromet*’ (MeSH Terms), ‘walking speed’ (MeSH
Terms), ‘kinematic’, ‘kinematic analysis’, ‘Timed Up and
Go’, ‘TUG’, ‘gait speed’, ‘gait speed test’, ‘walking speed
test’, ‘short physical performance battery’, ‘SPPB’, ‘six mi-
nute walk test’, ‘6 minute walk test’, ‘sit to stand test’, ‘sin-
gle leg stance test’, ‘one leg stance test’, ‘functional reach
test’, ‘romberg test’ and ‘functional task´. The complete
search strategy report with all search terms is shown on-
line in supplementary appendix B. The grey literature da-
tabases, such as New York Academy of Medicine Grey
Literature Report, Grey Literature in Health Research and
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Open Grey were explored to detect any relevant unpub-
lished data. References were exported, and duplicates were
removed using citation management software (Mendeley
desktop V.1.19.2).
Eligibility criteria
Only studies published in full-text papers were included.
Abstracts in conference proceedings, poster presenta-
tions, notes or letters to the editor were excluded be-
cause they had insufficient detail to be evaluated. Each
study had to meet the following inclusion criteria:
1. Cohort studies examining the relationship between
functional kinematic parameters obtained by
instrumented analysis (e.g., electronic walkways,
wearable sensors, camera systems …) and incident
MCI or comparing these functional objective
parameters between confirmed MCI and a Control
Group formed by cognitively healthy individuals or
people with Alzheimer Disease.
2. RCTs assessing longitudinal changes in functional
objective parameters after different physical activity
interventions.
3. Studies that included patients with MCI diagnosed by
a specialist or which used validated diagnostic criteria
(e.g., Petersen’s et al. [11, 12, 14–16], Winblad et al.
[13]), supported by a score of 0.5 on the Clinical
Dementia Rating (CDR)) [46], < 26 on the Montreal
Cognitive Assessment (MoCa) [47, 48], or > 24 Mini-
Mental State Examination (MMSE) [48, 49], that
permited to confirm the diagnosis of MCI.
4. Studies recruiting participants from any setting
(general population, primary, secondary or tertiary
care).
5. Studies written in English or Spanish.
The exclusion criteria were as follows:
1. All studies not including a longitudinal design (e.g
cross-sectional studies).
2. Studies that included the relationship between
functional parameters and incident MCI but did
not include a kinematic instrumented analysis.
3. Studies exploring the relationship between
functional kinematic parameters and cognitively
healthy individuals or people with other neurologic
diseases different from MCI.
4. Studies examining the relationship between MCI
and other different kinematic parameters such as
graphomotor functions, handwriting process
variables, etc.
5. Studies that evaluated the relationship between
functional kinematic parameters and brain
structures in patients with MCI.
6. Studies that did not include validated diagnostic criteria
of MCI, did not specify how those patients with MCI
were diagnosed or used a diagnosis based on a MMSE
score of less than 24, which could be indicative of a
greater dementia than the MCI [48–52].
Study selection
All studies identified by the search strategy were screened
using the eligibility criteria previously specified. Two inde-
pendent reviewers (IJ-FA and A-CV) carried out the first
stage, which involved the screening of titles and abstracts
to identify potentially relevant records. If the reviewers
were unable to determine a study’s eligibility based on title
and abstract, the full text was retrieved. In this first stage,
the two reviewers also excluded those documents that
were not full-text papers. The same reviewers undertook
the second stage, screening those articles that met all in-
clusion criteria. A short checklist was carried out to the
present review in order to guide the selection of relevant
studies (supplementary appendix C).
Data extraction
Two independent reviewers (IJ-FA and A-CV) extracted
the following relevant data from each study: study details
(first author, year of publication), study design, length of
follow up, sample size and characteristics of participants
(mean age), functional assessment or test used to assess
functional parameters, physical activity intervention, in-
strument used to kinematic analysis and the methods
used to diagnose or assess MCI.
Quality assessment
Two independent reviewers (IJ-FA and A-CV) assessed
the risk of bias of the included cohort studies using the
NOS [53]. The NOS is a reliable and valid tool for asses-
sing the quality of non-randomized studies [53] and as-
signs up to a maximum of nine points for the least risk
of bias in three domains: selection of study groups (four
points); comparability of groups (two points); and ascer-
tainment of exposure and outcomes (three points). The
risk of bias of the included RCTs was assessed using The
Cochrane Collaboration’s tool [54]. The Cochrane Col-
laboration’s tool includes seven domain or sources of
risk or bias assessment: random sequence generation, al-
location concealment, selective reporting, blinding of
participants and personnel, blinding of outcome assess-
ment, incomplete outcome data and other bias. For each
domain, the risk is categorized as “low risk”, “high risk”
or “unclear risk”. To assess the overall quality and the
strength of the evidence per outcome, the GRADE ap-
proach was used [55]. In brief, the GRADE classification
was carried out according to the presence, or not, of the
following identified factors: (i) study design, (ii) risk of
bias, (iii) inconsistency of results (iv) indirectness (v)
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imprecision, and (vi) other considerations (e.g. reporting
bias). Two researchers (IJ-FA and A-CV) judged whether
these factors were present for each outcome. The
GRADE criteria was applied when each outcome was in-
formed at least by two studies with the same design. The
level of evidence per outcome based on the GRADE cri-
teria is classified as: (1) high (further research is unlikely
to change our confidence in the estimate of effect and
there are no known or suspected reporting biases); (2)
moderate (further research is likely to have an important
effect on our confidence in the estimate of effect and
might change the estimate); (3) low (further research is
likely to have an important effect on our confidence in the
estimate of effect and is likely to change the estimate); or
(4) very low (we are uncertain about the estimate) [55].
Data synthesis and analysis
It was planned to conduct a meta-analysis of functional
kinematic parameters such as gait, balance, posture or
mobility, that could be indicative of MCI. However, due
to an observed heterogeneity across studies in the type
of design, methods of functional assessment, instruments
used to conduct a kinematic analysis, duration of follow-
up, statistical analysis, interventions and data presenta-
tion, the statistical pooling of results was deemed not
appropriate. Therefore, a meta-analysis of results was
not conducted, and a descriptive quantitative analysis
was carried out. For this reason, a narrative synthesis of
the most relevant summary measure and the main
change from baseline was reported.
Results
Study characteristics
A total of 2239 citations were identified through elec-
tronic databases, with 0 additional studies identified
through Grey Literature sources. One thousand one
hundred fifty-seven titles and abstracts were screened,
and 277 full-text papers were assessed. The number of
studies retrieved from each database and the number of
studies excluded in each screening phase are shown in
Fig. 1. The full reference of excluded studies in the sec-
ond stage (n = 260) is reported online in supplementary
appendix D. The conflict of interests of included studies
are shown online in supplementary appendix E. Of
these, 17 studies (six RCTs, one pilot RCT study, one
pilot cohort study, eight cohort studies and a reliability
study) with a total of 478 participants with MCI and
1540 cognitively healthy individuals at baseline, were in-
cluded in this review. The characteristics of the included
RCTs and the main results are reported in Table 1. The
results of cohort studies which compared functional ob-
jective parameters between confirmed MCI and a Con-
trol Group are reported in Table 2. The characteristics
of cohort studies examining the relationship between
functional kinematic parameters and incident MCI are
showed in Table 3. Functional kinematic parameters
were obtained by wearable sensors, tri-axial accelerome-
ters, digital balance platform, motion and contact sen-
sors, cameras and electronic walkways such as the GAIT
Rite (see Table 4). The most frequently used diagnosis
criteria of MCI were Petersen criteria (n = 7, 41%) and
the combination of the CDR (n = 9, 53%) and MMSE
(n = 11, 65%) (see Table 5).
Functional objective parameters after physical activity
interventions
RCTs showed that gait speed, cadence, stride length,
smoothness of trunk movement in the vertical direction
could be improved by aerobic exercises (60% of aged
predicted maximal heart rate), especially when aerobic
exercises are performed alongside cognitive stimulation
exercises or others physical exercises such as muscle
strength training, postural balance retraining, or gait
training [56, 57, 62]. Stride time and the total time to
perform the TUG also could be improved by the same
interventions [56, 57]. The center of mass sway in
anterior-posterior and medial-lateral directions also may
be improved by the balance training [58].
Functional objective parameters predicting MCI or
discriminating MCI patients from a control group
Cohort studies suggested that a slower gait speed in ST
condition and, above all, in DT conditions (counting
backwards) was the parameter that best discriminated
patients with MCI from cognitively healthy individuals
[63, 67, 68]. Larger gait speed variability could also dis-
criminate patients with MCI from cognitively healthy in-
dividuals [64, 67]. However, the total time to perform
the TUG and the different subtask of the TUG, was the
parameter which best discriminated patients with MCI
from patients with Alzheimer disease instead of the gait
speed, because patients with MCI took lower time in
performing the TUG [65]. On the other hand, cohort
studies showed that larger gait variability or larger gait
speed variability could predict an incident MCI [70, 71].
Decreased cadence and walk-regularity also were associ-
ated with an incident MCI [73].
Methodological quality
The methodological quality assessment of RCTs included
is shown in supplementary Table 1. In summary, RCTs
showed an unclear risk of bias, being the allocation con-
cealment and the blinding of outcome assessment the
ítems worst defined. Most of the included cohort studies
(60%) reported low risk of bias while the rest (40%)
showed moderate risk of bias (supplementary Table 2).
Comparability was the main source of bias in cohort
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studies. The GRADE criteria showed a low level of evi-
dence per outcome (supplementary Table 3).
Discussion
Statement of principal findings and comparision with
others studies
The objective of this study was to review the current state
of knowledge on the presence of functional kinematic pa-
rameters which may predict a future risk of MCI, could
discriminate patients with MCI from a control group and
could even be improved after different physical activity in-
terventions. To our knowledge, this is the first systematic
review that provides a comprehensive overview of longitu-
dinal studies (RCTs and cohort studies) using an instru-
mented kinematic assessment of functional task as
outcome measures or as parameters which could be im-
paired in patients with MCI or may predict an incident
MCI. Furthermore, most of the studies included in this
review were published after 2015, which indicates the nov-
elty of the topic [57–63, 65, 68, 70–73].
Cohort studies showed that slower gait speed in ST
condition and DT conditions (counting backwards), as
well as a larger gait speed variability were the parameters
that best discriminated patients with MCI from cogni-
tively healthy individuals [64, 67, 68]. Slower gait speed
in ST and DT conditions, as well as the time to perform
the TUG were the parameters that best discriminated
patients with MCI from patients with Alzheimer disease
[63, 65]. Some studies have identified a slower gait speed
in patients with MCI in comparison with cognitively
healthy individuals [25–27, 29, 34, 35, 40]. Bahureksa
et al. [40] also showed that a shorter stride length, a lon-
ger time to perform the stride (stride time) and a larger
variability of these parameters may discriminate patients
with MCI from cognitively healthy individuals. Verghese
et al. [29] added a decreased cadence, a larger swing
time variability, and a longer time to perform the swing
Fig. 1
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phase, stance phase and double support phase, as param-
eters which could be impaired in patients with MCI in
comparison with cognitively healthy controls. A previous
systematic review also demonstrated slower gait speed
and larger gait speed variability in patients with MCI
than in cognitively healthy individuals [74].
Thus, larger gait variability, above all in DT conditions,
could be associated with MCI [26]. In our review, cohort
studies showed that a larger gait variability or a larger gait
speed variability could predict an incident MCI [70, 71]. Sev-
eral studies have also reported that a slow gait speed and a
larger gait variability seem to be the main parameters which
could predict a future cognitive decline and may be useful in
the early detection of MCI [24, 26, 28, 30–33, 36, 75]. De-
creased cadence, walk-regularity and slower gait speed were
other kinematic parameters in our review which may be as-
sociated with an incident MCI [70, 73].
In the current review, RCTs suggested that gait speed,
stride length, stride time, balance and the time to per-
form the TUG may be improved by aerobic exercises
(60% of aged predicted maximal heart rate), especially
when aerobic exercises are performed alongside cogni-
tive stimulation exercises or others physical exercises
such as muscle strength training, postural balance
retraining, or gait training [56–58, 61]. Nevertheless,
sample sizes were small in most of the included studies
[56–59, 61, 62]. A previous study showed limited evi-
dence on intervention effects on stride time variability
[76] although this parameter seems to be a important
predictor of MCI [58, 61, 63]. The combination of aerobic
exercise, balance training and cognitive training could help re-
duce the risk of further cognitive impairment and may improve
cognition, mobility, balance and quality of life [41, 43]. Further-
more, some systematic reviews and meta-analysis showed that
aerobic and resistance (strength) exercises, join cognitive train-
ing could improve cognitive function, activities in daily living
and mood [77–80].
Strengths and weaknesses of the study
The strengths of this systematic review included the use
of a pre-specified protocol registered on PROSPERO,
the PRISMA checklist, the NOS and The Cochrane Col-
laboration’s tool to determine the risk of bias of included
studies and the GRADE criteria to assess the level of evi-
dence per outcome. Furthermore, this review only in-
cluded studies which provided a validated diagnostic
criteria of MCI. There are several limitations that should
be mentioned. First, it is possible that some studies were
not identified, although we conducted a robust search
strategy in order to avoid it. Second, the lack of uniform-
ity among the study design (e.g. walking distance, vari-
ables measured, different instruments used in kinematic
analysis) should be taken into account when interpreting
the results. In the literature, it has been demonstrated
that participant walking strategy changes with walking
distance, resulting in a significant effect on gait variabil-
ity [81], so walking distance could be highly relevant in
order to measure gait variability as a marker for MCI.
Furthermore, studies did not report the reliability, valid-
ity or responsiveness of the instruments used in kine-
matic analysis, so we could not show what motion
capture instrument is the most effective to perform the
kinematic analysis. Third, RCTs reported an “unclear”
risk of bias, so no firm conclusions should be drawn.
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MCI Mild cognitive impairment, RCT Randomized Controlled Trial, aMCI Amnestic mild cognitive impairment, MMSE Mini-mental State Examination, L3 Third
lumbar vertebra level, HR Harmonic ratio that represent the smoothness of trunk movement, VT Vertical direction, PCT Combined simultaneous Physical and
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*p > 0.05. **p < 0.05. ***p < 0.001
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Implications for clinical practice
Our results showed kinematic gait parameters which
could be impaired and may predict an incident MCI.
This is an important step forward in developing a
clinically validated approach for measuring MCI related
functional deficits which could predict a future risk of
MCI and could even help its early diagnosis, although
further studies are required in order to validate the
Table 2 Summary of included Cohort studies which compared Instrumented Objective Functional Parameters between Confirmed
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Table 4 Instruments used in kinematic analysis
Instrument Papers n, % References
Tri-axial accelerometer (e.g. Locometrix®, etc.) 4, 23.5% [56, 60, 63, 70]
Electronic walkway (e.g. GAITRite®, etc.) 4, 23.5% [57, 59, 68, 69]




Inertial measurement units (IMUs) 1, 6% [61]
Motion and contact sensors 4, 23.5% [64, 67, 71, 72]
Qualisys ProReflex motion analysis System (cameras) 1, 6% [65]
GAIT Up System. 1, 6% [62]
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findings of this review. Findings of this systematic review
also could be useful for promoting specific interventions
which could revert the functional changes associated
with MCI, since RCTs included in this systematic review
have demonstrated that physical activity interventions
could improve some functional objective parameters.
Implications for further research
Despite the promising results of the present study, some
flaws observed in most of the included studies in this re-
view should be resolved. Hence, there are some recom-
mendations to guide future research: (i) studies should use
the same instrument to perform the kinematic analysis
which would allow a better comparison of data between
studies; (ii) these instruments should be valid and reliable
as established in the Cosmin taxonomy; (iii) RCTs and
Cohort studies with high quality of evidence should be
conducted since studies included in this systematic review
often showed an unclear risk of bias and a low quality of
evidence; (iv) Clinical trials which use functional objective
parameters as outcome measures of physical activity inter-
ventions in MCI also should be conducted.
Conclusion
Slower gait speed in ST condition and, above all, in DT
conditions and larger gait speed variability are the pa-
rameters that best discriminate patients with MCI from
a control group. Slower gait speed and larger gait vari-
ability may also predict an incident MCI or could even
help its early diagnosis. Some functional objective pa-
rameters such as gait speed, stride length, stride time,
balance and the time to perform the TUG may be im-
proved by aerobic exercises when aerobic exercises are
performed alongside cognitive stimulation exercises or
others physical exercises such as muscle strength train-
ing, postural balance retraining, or gait training. Al-
though most of the cohort studies showed a low risk of
bias, RCTs reported unclear risk of bias and GRADE cri-
teria showed a low level of evidence per outcome, so fur-
ther studies are required to confirm our findings.
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